- Home
- IKNA vs MATH Comparison
IKNA vs MATH Comparison
Compare IKNA & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- MATH
- Stock Information
- Founded
- IKNA 2016
- MATH 2015
- Country
- IKNA United States
- MATH Hong Kong
- Employees
- IKNA N/A
- MATH N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- MATH Finance/Investors Services
- Sector
- IKNA Health Care
- MATH Finance
- Exchange
- IKNA Nasdaq
- MATH Nasdaq
- Market Cap
- IKNA 61.8M
- MATH 60.8M
- IPO Year
- IKNA 2021
- MATH N/A
- Fundamental
- Price
- IKNA $1.08
- MATH $2.12
- Analyst Decision
- IKNA Buy
- MATH
- Analyst Count
- IKNA 2
- MATH 0
- Target Price
- IKNA $3.00
- MATH N/A
- AVG Volume (30 Days)
- IKNA 95.3K
- MATH 84.8K
- Earning Date
- IKNA 05-20-2025
- MATH 01-01-0001
- Dividend Yield
- IKNA N/A
- MATH N/A
- EPS Growth
- IKNA N/A
- MATH N/A
- EPS
- IKNA N/A
- MATH 0.17
- Revenue
- IKNA N/A
- MATH $31,399,049.00
- Revenue This Year
- IKNA N/A
- MATH N/A
- Revenue Next Year
- IKNA N/A
- MATH N/A
- P/E Ratio
- IKNA N/A
- MATH $11.51
- Revenue Growth
- IKNA N/A
- MATH 291.58
- 52 Week Low
- IKNA $0.97
- MATH $0.80
- 52 Week High
- IKNA $1.94
- MATH $2.78
- Technical
- Relative Strength Index (RSI)
- IKNA 37.62
- MATH 63.69
- Support Level
- IKNA $1.22
- MATH $1.85
- Resistance Level
- IKNA $1.29
- MATH $2.08
- Average True Range (ATR)
- IKNA 0.09
- MATH 0.17
- MACD
- IKNA -0.01
- MATH 0.04
- Stochastic Oscillator
- IKNA 1.75
- MATH 100.00
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.